X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (53658) 53658
Newsletter (1236) 1236
Magazine Article (99) 99
Newspaper Article (41) 41
Dissertation (32) 32
Book Chapter (31) 31
Publication (20) 20
Conference Proceeding (11) 11
Book Review (6) 6
Reference (6) 6
Book / eBook (5) 5
Web Resource (4) 4
Government Document (2) 2
Streaming Video (2) 2
Journal / eJournal (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (41383) 41383
female (26619) 26619
male (22376) 22376
middle aged (22130) 22130
fluorouracil - administration & dosage (21622) 21622
oncology (20654) 20654
aged (19251) 19251
fluorouracil (18951) 18951
antineoplastic combined chemotherapy protocols - therapeutic use (17156) 17156
adult (16003) 16003
chemotherapy (14357) 14357
cancer (11942) 11942
fluorouracil - therapeutic use (11122) 11122
5-fluorouracil (9211) 9211
treatment outcome (8480) 8480
animals (7802) 7802
fluorouracil - adverse effects (6414) 6414
fluorouracil - pharmacology (6277) 6277
colorectal cancer (6187) 6187
antineoplastic combined chemotherapy protocols - adverse effects (6112) 6112
combined modality therapy (6106) 6106
colorectal neoplasms - drug therapy (5941) 5941
cisplatin - administration & dosage (5660) 5660
leucovorin (5304) 5304
neoplasm staging (5293) 5293
prognosis (5232) 5232
surgery (5154) 5154
aged, 80 and over (5107) 5107
breast neoplasms - drug therapy (4968) 4968
leucovorin - administration & dosage (4835) 4835
antineoplastic combined chemotherapy protocols - administration & dosage (4673) 4673
chemotherapy, adjuvant (4620) 4620
care and treatment (4547) 4547
carcinoma (4509) 4509
mice (4500) 4500
oxaliplatin (4495) 4495
drug administration schedule (4443) 4443
research (4425) 4425
deoxycytidine - analogs & derivatives (4416) 4416
therapy (4376) 4376
colorectal neoplasms - pathology (4325) 4325
capecitabine (4312) 4312
adenocarcinoma - drug therapy (4293) 4293
survival rate (4278) 4278
disease-free survival (4132) 4132
survival (4073) 4073
fluorouracil - analogs & derivatives (4067) 4067
pharmacology & pharmacy (3961) 3961
retrospective studies (3924) 3924
cisplatin (3904) 3904
antineoplastic agents - therapeutic use (3705) 3705
radiotherapy (3510) 3510
survival analysis (3506) 3506
follow-up studies (3395) 3395
neoplasm metastasis (3318) 3318
metastasis (3280) 3280
stomach neoplasms - drug therapy (3252) 3252
liver neoplasms - secondary (3187) 3187
organoplatinum compounds - administration & dosage (3168) 3168
time factors (3114) 3114
analysis (3085) 3085
antimetabolites, antineoplastic - therapeutic use (3080) 3080
trial (3080) 3080
medicine & public health (3074) 3074
liver neoplasms - drug therapy (3063) 3063
camptothecin - analogs & derivatives (3062) 3062
cyclophosphamide - administration & dosage (2987) 2987
colonic neoplasms - drug therapy (2925) 2925
deoxycytidine - administration & dosage (2845) 2845
antimetabolites, antineoplastic - administration & dosage (2824) 2824
irinotecan (2717) 2717
cell line, tumor (2620) 2620
carcinoma, squamous cell - drug therapy (2579) 2579
antineoplastic agents - administration & dosage (2523) 2523
prospective studies (2483) 2483
dose-response relationship, drug (2463) 2463
breast cancer (2430) 2430
methotrexate - administration & dosage (2427) 2427
drug therapy, combination (2370) 2370
doxorubicin - administration & dosage (2309) 2309
bevacizumab (2290) 2290
tumors (2281) 2281
breast neoplasms - pathology (2259) 2259
colorectal-cancer (2211) 2211
1st-line treatment (2206) 2206
health aspects (2159) 2159
camptothecin - administration & dosage (2148) 2148
apoptosis (2135) 2135
drug therapy (2134) 2134
combination (2078) 2078
expression (2078) 2078
lymphatic metastasis (2056) 2056
adenocarcinoma (2017) 2017
adenocarcinoma - pathology (2009) 2009
adjuvant chemotherapy (2009) 2009
infusions, intravenous (2005) 2005
gastroenterology & hepatology (1990) 1990
antineoplastic agents - pharmacology (1989) 1989
randomized-trial (1977) 1977
toxicity (1927) 1927
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (49438) 49438
Japanese (3680) 3680
German (1113) 1113
French (988) 988
Chinese (789) 789
Russian (615) 615
Italian (301) 301
Spanish (214) 214
Polish (101) 101
Portuguese (89) 89
Korean (78) 78
Hungarian (43) 43
Dutch (33) 33
Danish (32) 32
Czech (28) 28
Norwegian (26) 26
Hebrew (22) 22
Ukrainian (14) 14
Romanian (13) 13
Swedish (13) 13
Slovak (11) 11
Turkish (11) 11
Bulgarian (10) 10
Croatian (7) 7
Serbian (6) 6
Finnish (5) 5
Lithuanian (5) 5
Arabic (3) 3
Afrikaans (1) 1
Icelandic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2014, Volume 371, Issue 17, pp. 1609 - 1618
In patients with metastatic colon cancer, fluorouracil, oxaliplatin, and irinotecan plus bevacizumab, as compared with fluorouracil and irinotecan plus... 
1ST-LINE TREATMENT | MEDICINE, GENERAL & INTERNAL | INFUSIONAL FLUOROURACIL | LEUCOVORIN | MANAGEMENT | PHASE-III | GUIDELINES | IRINOTECAN | OXALIPLATIN | CHEMOTHERAPY | FOLFIRI | Follow-Up Studies | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Bevacizumab | Fluorouracil - therapeutic use | Antibodies, Monoclonal, Humanized - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Neoplasm Metastasis - drug therapy | Colorectal Neoplasms - drug therapy | Adult | Female | Leucovorin - therapeutic use | Liver Neoplasms - secondary | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - adverse effects | Camptothecin - adverse effects | Camptothecin - therapeutic use | Kaplan-Meier Estimate | Liver Neoplasms - drug therapy | Disease-Free Survival | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Colorectal Neoplasms - pathology | Organoplatinum Compounds - therapeutic use | Organoplatinum Compounds - adverse effects | Treatment outcome | Care and treatment | Analysis | Colorectal cancer | Dosage and administration | Leucovorin | Fluorouracil | Colorectal carcinoma | Diarrhea | Metastasis | Survival | Patients | Clinical outcomes | Metastases | Irinotecan | Stomatitis | Chemotherapy | Neurotoxicity | Oxaliplatin | Monoclonal antibodies | Vascular endothelial growth factor | Neutropenia | Index Medicus | Abridged Index Medicus
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2007, Volume 25, Issue 33, pp. 5210 - 5217
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 385, Issue 9980, pp. 1843 - 1852
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2008, Volume 26, Issue 12, pp. 2013 - 2019
Journal Article
The lancet oncology, ISSN 1470-2045, 2010, Volume 11, Issue 9, pp. 853 - 860
Summary Background Fluorouracil and folinic acid with either oxaliplatin (FOLFOX) or irinotecan (FOLFIRI) are widely used as first-line or second-line... 
Hematology, Oncology and Palliative Medicine | TRIAL | CAPECITABINE | 1ST-LINE TREATMENT | INFUSIONAL FLUOROURACIL/LEUCOVORIN | LEUCOVORIN | THERAPY | ONCOLOGY | 5-FLUOROURACIL/FOLINIC ACID | FLUOROPYRIMIDINE | OXALIPLATIN | FAILURE | Prodrugs - administration & dosage | Leucovorin - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Organoplatinum Compounds - administration & dosage | Fluorouracil - administration & dosage | Leucovorin - adverse effects | Fluorouracil - adverse effects | Colorectal Neoplasms - drug therapy | Adult | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Colorectal Neoplasms - mortality | Camptothecin - adverse effects | Fluorouracil - analogs & derivatives | Tegafur - adverse effects | Kaplan-Meier Estimate | Oxonic Acid - administration & dosage | Adenocarcinoma - drug therapy | Oxonic Acid - adverse effects | Disease-Free Survival | Prodrugs - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Tegafur - administration & dosage | Aged | Drug Combinations | Adenocarcinoma - mortality | Medical colleges | Chemotherapy | Oncology, Experimental | Colorectal cancer | Leucovorin | Research | Metastasis | Cancer | Fluorouracil | Analysis
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2009, Volume 27, Issue 33, pp. 5513 - 5518
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2008, Volume 358, Issue 1, pp. 36 - 46
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 19, pp. 3191 - 3198
Journal Article